Medica Share Discussion Threads

[nobilis] 08/5/2018 15:24

750k traded

[nobilis] 08/5/2018 09:59

Chart bowl up on high volume

[opodio] 08/5/2018 08:45

Nice 60k buy

[nobilis] 07/5/2018 10:15

Radiology is a highly fragmented $18 billion-plus industry.
Core market drivers that make radiology appealing to private equity include:

Market size
Highly fragmented market
Favorable demographics (i.e., aging population)
Increasing technology costs
Need for improved back-office operations
Increasingly central role in population health management
Importance of scale for success

In addition, there are a tremendous number of add-on opportunities.

Several factors that make private equity attractive to radiology groups include:

Physician leadership – First and foremost, quality of care is the most critical factor when deciding to partner. Unlike acquisitions by hospitals, radiology groups acquired by private equity often retain control over things like care protocols, hospital relationships, scheduling and other patient-centered activities.

Increasing technology needs – Compared with other specialties, radiology requires much higher technology capital expenditures. Faced with increasing costs, many groups recognize that their future compensation may likely decrease.

Shifting radiologist demographics – As baby boomers age, a large number of retirements are expected in the coming years. These retirees are often being replaced by younger radiologists who are less interested in running the business side of a practice.

[nobilis] 07/5/2018 10:13

double post

[thebigshortfella] 04/5/2018 10:25

Rubberbullets - why do you think that? Thanks.

[rubberbullets] 04/5/2018 10:02

Ready to shoot up

[nobilis] 03/5/2018 13:33

Women face delays in undergoing routine or urgent breast scans following the NHS cancer screening fiasco, doctors warned today.

A shortage of radiologists across the NHS, as well as the technicians who perform the scans, will make it a “challengeR21; to perform the thousands of extra scans necessary by October, the Royal College of Radiologists said.

Between 135 and 270 women may have died prematurely after not being called for their final routine mammogram since 2009 due to an IT error.

Women under 72 are now being contacted and invited at attend a catch-up check to see if breast cancer has been missed.


Should boost workloads which are already heaving at MGP

[rubberbullets] 03/5/2018 11:37

Heading higher
Beautiful bowl on chart

[stun12] 01/5/2018 17:32

I'd been rather put off by the dealing spread - often 5p or more - on the share as it fell below the IPO price, but liquidity seemed to pick up towards the close today and I grabbed a small toe-hold at 120.8. Medica doesn't appear to have much in the way of competition and this sort of outsourcing can only increase over time. A family member works there in a fairly menial position (so has no access to any inside info) and things remain quite busy most of the time. The key appears to be attracting new radiologists, so Medica's announcement at each earnings RNS of the number on board is an important part of it.

[lomax99] 30/4/2018 16:28

thebigshortfella - sorry to hear about your loss, I was £10k down by the time I had offloaded most of my holding.

opodio - well done!!

[thebigshortfella] 27/4/2018 14:24

Thanks lomax99. I doubt it will make you feel better, but I lost £27k on this dog.

I am slightly dubious of the management here. I get all the talk around utilising technology - but it just looks and feels a bit tinpot to me.

Regardless, I am conscious that my biases may blind me from seeing an opportunity to ride a (perhaps short lived) recovery trading opportunity.

Good luck fella.

[lomax99] 27/4/2018 13:48

A disgruntled holder, Grrrh!

Reluctantly sold most of mine at a somewhat higher level, crystallising a decent loss. I now have a fairly small holding, which I added to recently around the current level. Not sure this has much that much further to fall (famous last words...), hoping to recoup some of my losses taking a 6 - 24 month view. IMO DYOR.

[thebigshortfella] 27/4/2018 13:14

lomax99 - what’s your take on MGP please? Thanks.

The share price seems to have support at this level. I am tempted to put a small trade in them with a tightish stop.

[lomax99] 27/4/2018 12:11

Good idea to get the Directors Remuneration signed off(today's RNS)!

[steve3sandal] 12/4/2018 19:49

Approx 170/ 180/ 190/ 220 and 119p earlier this week. Fortunately I have had more success elsewhere!

[thebigshortfella] 12/4/2018 19:04

steve3sandal - if you don’t mind me asking, what did you buy in at?

I am contemplating whether this is a recovery play....

Thanks.

[steve3sandal] 12/4/2018 13:07

It seems remarkable that Liontrust and SEC can buy over 6 million shares whilst all the time the price has been falling. A lot of PIs must have been selling as there are no obvious institional reductions. Hopefully that was the bottom in. Edit, I missed the Quilter RNS down from 18 to 16%.
What went wrong was a growth rating without a corresponding growth in earnings. I have some lingering concern regarding cash conversion, lack of NHS trust client growth and this mornings news that they now have a dozen sites to locate radiologist staff which must come with additional costs. Not quite a digital as I hoped if they need 12 office locations. Liontrust and SEC are no mugs and I am trying to take some comfort from their buying....it’s been a difficult quarter.

[ali47fish] 12/4/2018 12:11

Strategic Equity Capital plc is adding- what is going on?

[ali47fish] 09/4/2018 15:48

lomax i very much appreciate your comments

[robmal] 09/4/2018 15:14

I see Liontrust has increased their holding by over 5%. They now hold 10.26% in total. Are MM’s dropping the price in order to gain stock?

[lomax99] 29/3/2018 05:49

ali47fish-I reduced my holding significantly, crystallising a loss, following their 'miss' on revenue growth (c. 18, not 20%)/profits, with lower forward revenue guidance. I think the fall in the share price has been overdone, yet it continues to fall.They are a clear market leader, with nearly 50% gross margins, in a market which is likely to see continued strong growth in the short/medium term. AI has been stated as being a disruptor, I suspect however that's a long way off....I have just bought back a few, and intend to add progressively more should the share price decline continue, assuming new information/insight does not arise to alter my view of their prospects.Are they a buy, hold or sell? Ultimately that decision is yours.